Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06957808) titled 'Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia' on May 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: King's College London
Condition:
Schizophrenia Disorders
Intervention:
Drug: Diroximel fumarate (DRF)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 10, 2025
Target Sample Size: 30
Countries of Recruitment:
United Kingdom
To know more, visit https://clinicaltrials.go...